- Joined
- Apr 29, 2011
- Messages
- 2,171
- Reaction score
- 863
Current (2016) edition of FA indicates that Beta2-binding causes increased insulin release.
Previous editions of FA (although not the current one I think) and Wikipedia (see quote below) indicate that Beta2-binding causes increased glucagon release.
"Hypoglycemia can occur with beta blockade because β2-adrenoceptors normally stimulate hepatic glycogen breakdown (glycogenolysis) and pancreatic release of glucagon, which work together to increase plasma glucose. Therefore, blocking β2-adrenoceptors lowers plasma glucose. "
https://en.wikipedia.org/wiki/Beta_blocker#Adverse_effects
So is it both?
Assuming it is both, then why would Beta2-blockage cause the hypoglycemia effect illustrated in the Wikipedia quote? Blocking Beta2 ==> blocking insulin AND glucagon ==> ??? ==> hypoglycemia?
Previous editions of FA (although not the current one I think) and Wikipedia (see quote below) indicate that Beta2-binding causes increased glucagon release.
"Hypoglycemia can occur with beta blockade because β2-adrenoceptors normally stimulate hepatic glycogen breakdown (glycogenolysis) and pancreatic release of glucagon, which work together to increase plasma glucose. Therefore, blocking β2-adrenoceptors lowers plasma glucose. "
https://en.wikipedia.org/wiki/Beta_blocker#Adverse_effects
So is it both?
Assuming it is both, then why would Beta2-blockage cause the hypoglycemia effect illustrated in the Wikipedia quote? Blocking Beta2 ==> blocking insulin AND glucagon ==> ??? ==> hypoglycemia?